文献速递冠心病

定义对2型心肌梗死发生率与预后的影响

Effect of Definition on Incidence and Prognosis of Type 2 Myocardial Infarction.
PubMed 文献 · J Am Coll Cardiol · 2017-01-01

本研究在4015例疑似心肌梗死患者中,由两位独立心内科医生按2007年(要求冠心病)和2012年(不要求冠心病)通用定义裁定2型心肌梗死。2012年定义使T2MI发生率相对增加114%,但重新分类的患者90天心血管死亡率为0%,显著低于2007年定义组和1型心肌梗死组。

要点

  • 2012年定义使T2MI发生率增加114%,重新分类患者90天心血管死亡率为0%。
  • 2007年定义组接受血运重建、双联抗血小板及高强度他汀治疗的比例均显著更高。
  • 重新分类T2MI患者预后与无心脏原因的胸痛患者相似,提示其风险较低。

核心结论

  • 按2012年定义重新分类的2型心肌梗死患者事件相关死亡率显著低于2007年定义组和1型心肌梗死组。

研究设计与样本

  • 在4015例连续入组的疑似心肌梗死患者中,由两位独立心内科医生分别按2007年与2012年通用定义裁定2型心肌梗死。

主要发现

  • 2007年定义T2MI发生率为2.8%(n=112),2012年定义使T2MI发生率增加6%(n=240),相对增加114%(128例重新分类为T2MI2012reclassified)。
  • T2MI2007组接受冠脉血运重建6.3%、双联抗血小板22%、高强度他汀71%,T2MI2012reclassified组分别为0.8%、1.6%、31%(均p<0.01)。
  • 90天心血管死亡率:T2MI2012reclassified为0%,非心脏原因胸痛为0.2%,T2MI2007为3.6%,T1MI为4.8%(T2MI2012reclassified vs T2MI2007和T1MI:p=0.03和0.01)。

临床怎么用

  • 采用2012年通用定义可能将低危患者归为T2MI,需注意与2007年定义组在治疗强度和预后上的差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Uncertainties regarding the most appropriate definition and treatment of type 2 myocardial infarction (T2MI) due to supply-demand mismatch have contributed to inconsistent adoption in clinical practice. OBJECTIVES: This study sought a better understanding of the effect of the definition of T2MI on its incidence, treatment, and event-related mortality, thereby addressing an important unmet clinical need. METHODS: The final diagnosis was adjudicated in patients presenting with symptoms suggestive of myocardial infarction by 2 independent cardiologists by 2 methods: 1 method required the presence of coronary artery disease, a common interpretation of the 2007 universal definition (T2MI2007); and 1 method did not require coronary artery disease, the 2012 universal definition (T2MI2012). RESULTS: Overall, 4,015 consecutive patients were adjudicated. The incidence of T2MI based on the T2MI2007 definition was 2.8% (n = 112). The application of the more liberal T2MI2012 definition resulted in an increase of T2MI incidence of 6% (n = 240), a relative increase of 114% (128 reclassified patients, defined as T2MI2012reclassified). Among T2MI2007, 6.3% of patients received coronary revascularization, 22% dual-antiplatelet therapy, and 71% high-dose statin therapy versus 0.8%, 1.6%, and 31% among T2MI2012reclassified patients, respectively (all p < 0.01). Cardiovascular mortality at 90 days was 0% among T2MI2012reclassified, which was similar to patients with noncardiac causes of chest discomfort (0.2%), and lower than T2MI2007 (3.6%) and type 1 myocardial infarction (T1MI) (4.8%) (T2MI2012reclassified vs. T2MI2007 and T1MI: p = 0.03 and 0.01, respectively). CONCLUSIONS: T2MI2012reclassified has a substantially lower event-related mortality rate compared with T2MI2007 and T1MI. (Advantageous Predictors of Acute Coronary Syndromes Evaluation [APACE] Study; NCT00470587).

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Nestelberger T, Boeddinghaus J, Badertscher P, et al. Effect of Definition on Incidence and Prognosis of Type 2 Myocardial Infarction. J Am Coll Cardiol. 2017. PMID: 28935032. doi:10.1016/j.jacc.2017.07.774

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。